mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
5e-08 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
5e-08 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-08 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-07 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-07 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-07 |